Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scientists at the London Research Institute of CRUK Use the Linkam CMS196

Published: Thursday, November 07, 2013
Last Updated: Thursday, November 07, 2013
Bookmark and Share
Scientists use CMS196 stage for the imaging of mammalian cells with Cryo-CLXM microscopy.

Linkam Scientific Instruments has reported on the use of their innovative CMS196 cryo stage for the study of mammalian cells at the London Research Institute, Cancer Research UK.

For mammalian cells to remain in a healthy state, they require constant renewal of their components. The process of disposing of old components is known as 'autophagy', which stems from the Greek words auto "self" and phagein "eat".

This process involves the formation of a double-membrane structure called an autophagosome, which engulfs old or dysfunctional organelles and then fuses with lysosomes, where they are broken down to recycle the constituent molecules.

Autophagy is increased when cells are starved, and plays a fundamental role in a large number of cellular processes, including development, immunity, neurodegeneration and cancer.

In a recent publication in the journal, Ultramicroscopy (Duke et al., 2013), Dr Lucy Collinson (LRI Electron Microscopy Unit), in collaboration with Dr Sharon Tooze (LRI Secretory Pathways Lab), imaged forming autophagosomes in whole mammalian cells.

The structures are particularly difficult to capture in cells prepared for electron microscopy, so they are now using a powerful new technique called cryo-soft X-ray tomography, cryo-SXT, working with Dr Liz Duke at the Diamond Light Source synchrotron.

This allows whole mammalian cells to be imaged as close to the living state as possible. The cells are grown on tiny gold grids and plunged into liquid ethane to preserve the cells in the frozen state.

In order to find the autophagosomes within the cells, they are labelled with green fluorescent protein (GFP). The fluorescent autophagosomes are then located using a technique called correlative cryo-fluorescence and cryo-soft x-ray microscopy (cryo-CLXM).

Cryo-fluorescence microscopy is performed using the Linkam CMS196 stage prior to the cells being transported in cryo-containers to synchrotrons in Oxfordshire, Berlin and Barcelona for imaging. One of the major advantages of this new correlative approach is that the CMS196 stage allows the cells to be screened for quality and protein localization in the research laboratory before actually travelling to the synchrotron, which is critical in terms of cost and efficiency.

The combination of cryo-fluorescence microscopy and cryo-SXT allows scientists to link the functionality of proteins to their near native-state structure. This should find wide applications in cell biology studies of health and disease.

The Linkam CMS196 stage was designed specifically to solve the problem of how to get vitrified EM grids from the fluorescence microscope into the cryo-TEM without devitrification and contamination through condensation. The stage has been optimized optically to enable the use of high NA lenses.

Up to 3 grids can be loaded into a specially designed cassette for transportation from the plunge freezer to the upright fluorescent microscope. The cassette is then easily loaded onto the viewing bridge using special manipulation tools.

The sample viewing chamber is perfectly dry and below -180ºC while the sample bridge itself is at -196°C. The grids can be quickly and efficiently scanned using a 100X 0.75NA lens and manipulated using high precision micrometers. The cassette is then simply manipulated back into the transportation device and is then transported to the cryo-TEM under liquid nitrogen.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!